TW206205B - - Google Patents

Download PDF

Info

Publication number
TW206205B
TW206205B TW079107702A TW79107702A TW206205B TW 206205 B TW206205 B TW 206205B TW 079107702 A TW079107702 A TW 079107702A TW 79107702 A TW79107702 A TW 79107702A TW 206205 B TW206205 B TW 206205B
Authority
TW
Taiwan
Prior art keywords
compound
test
effect
isomer
pregnant
Prior art date
Application number
TW079107702A
Other languages
English (en)
Chinese (zh)
Original Assignee
Hokuriku Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical filed Critical Hokuriku Pharmaceutical
Application granted granted Critical
Publication of TW206205B publication Critical patent/TW206205B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW079107702A 1989-09-28 1990-09-13 TW206205B (Direct)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25042489 1989-09-28
JP20247690 1990-08-01

Publications (1)

Publication Number Publication Date
TW206205B true TW206205B (Direct) 1993-05-21

Family

ID=26513407

Family Applications (1)

Application Number Title Priority Date Filing Date
TW079107702A TW206205B (Direct) 1989-09-28 1990-09-13

Country Status (6)

Country Link
EP (1) EP0420120B1 (Direct)
JP (1) JPH07119189B2 (Direct)
KR (1) KR950000778B1 (Direct)
CA (1) CA2026216C (Direct)
DE (1) DE69012031T2 (Direct)
TW (1) TW206205B (Direct)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842658B1 (en) * 1995-08-04 2003-05-21 Hokuriku Seiyaku Co., Ltd. Photostable aqueous solution containing benzyl alcohol derivatives
JP4685201B2 (ja) * 1996-08-19 2011-05-18 キッセイ薬品工業株式会社 頻尿および尿失禁の予防・治療剤
AU5066898A (en) * 1996-11-26 1998-06-22 Mitsubishi Chemical Corporation Optically active methoxyiminoacetamide derivatives, process for the preparation of them, intermediates therefor, and pesticides containing them as the active ingredient
DE19956786A1 (de) * 1999-11-25 2001-05-31 Basf Ag Verfahren zur Herstellung optisch aktiver Amine
BR0316080A (pt) 2002-11-07 2005-09-27 Astellas Pharma Inc Remédio para bexiga superativa compreendendo derivado de ácido acético anildo como o ingrediente ativo
JP2007502865A (ja) * 2003-05-23 2007-02-15 ブリッジ ファーマ、インコーポレイテッド 平滑筋鎮痙剤
WO2006048720A1 (en) * 2004-11-08 2006-05-11 Emcure Pharmaceuticals Limited An efficient method for preparation of (s)-3-[(1-dimethyl amino)ethyl]-phenyl-n-ethyl-n-methyl-carbamate
WO2012030938A1 (en) * 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS609293B2 (ja) 1978-06-29 1985-03-09 カシオ計算機株式会社 キ−入力制御方式

Also Published As

Publication number Publication date
JPH07119189B2 (ja) 1995-12-20
CA2026216A1 (en) 1991-03-29
JPH04178356A (ja) 1992-06-25
KR910006213A (ko) 1991-04-27
DE69012031D1 (de) 1994-10-06
EP0420120A2 (en) 1991-04-03
CA2026216C (en) 1998-12-01
EP0420120A3 (en) 1991-09-11
EP0420120B1 (en) 1994-08-31
DE69012031T2 (de) 1995-01-26
KR950000778B1 (ko) 1995-02-02

Similar Documents

Publication Publication Date Title
TW200406375A (en) Aminotetralin-derived urea modulators of vanilloid VR1 receptor
JP2020534264A (ja) ベータ−ヒドロキシ複素環アミンおよび高血糖症の治療におけるそれらの使用
TWI848911B (zh) 以三唑并吡啶治療rbp4相關疾病之方法
TWI841532B (zh) 以稠合雙環吡唑治療代謝疾病之方法
RU2478621C2 (ru) Производное циклогексана и его фармацевтическое применение
TW206205B (Direct)
JPH08512038A (ja) 胃腸障害の治療に関するフェネタノールアミン誘導体の用途
WO2011160597A1 (zh) 一种具有降高血压活性的呋喃香豆素类化合物及其制备方法
TW219329B (Direct)
JP7050336B2 (ja) 重水素化化合物及びその医薬的用途
SU1486062A3 (ru) Способ получения ν-алкилированной дигидролизергиновой кислоты
KR20180095665A (ko) 징코라이드b 유도체, 그 제조 방법 및 응용
JPH0770013A (ja) β３ −アドレナリン作動薬として作用する｛（７Ｓ）−７−［（２Ｒ）−２−（３−クロロフェニル）−２−ヒドロキシエチルアミノ］−５，６，７，８−テトラヒドロナフタレン−２−イルオキシ）酢酸及びその薬学的に許容されうる塩、並びにそれらが存在する薬学的組成物及び研究室用試薬
JPH02502997A (ja) アミノアルキル側鎖を有する環状炭化水素
TW202246217A (zh) 咪唑醯胺衍生物及其製備方法和應用
US10730836B2 (en) Forms of apremilast
WO2023160004A1 (zh) 具有镇痛活性的稠环化合物及其制备方法与用途
JPS62195392A (ja) ジヒドロピリジン−５−ホスホンアミド酸類
JP2002533320A (ja) 疼痛管理に有用な新規なオキソ−アミノテトラリン化合物
EP0251126B1 (en) 1,7-substituted heptyne-2-ones
CN107056819B (zh) 一种预防和治疗心肌缺血的药物及其制备方法
JP2001181251A (ja) アスピリン誘導体、その製造方法、並びにこれを有効成分として含有する抗炎症剤
JP3571114B2 (ja) 麻薬拮抗剤
US5036107A (en) 1,7-substituted heptyn-2-ones and use
JP2007530424A (ja) 新規Ｎ−ヒドロキシ−４−（３−フェニル−５−メチル−イソオキサゾール−４−ｙｌ）−ベンゼンスルホンアミドの溶媒和物